Significant differences in MAGE-A4 positive expression rates are observed in peripheral blood mononuclear cells of HCC patients at different pathological stages, with rates reaching 40% in advanced patients compared to only 6.7% in early stages, indicating a positive correlation between MAGE-A4 expression levels and disease progression. Here, MAGEA4 is linked to hepatocellular carcinoma.